CSIR Central

REVERSIBLE SUPPRESSION OF NITRIC OXIDE SYSTEM IN ESSENTIAL HYPERTENSION

IR@CDRI: CSIR-Central Drug Research Institute, Lucknow

View Archive Info
 
 
Field Value
 
Creator Chandra, M
Maurya, D R
Kumar, S
Basara, H
Ghatak, Ashim
Tekwani, B L
Kaur, G
Misra, M K
 
Date 2008-01-17T10:31:35Z
2008-01-17T10:31:35Z
2003
 
Identifier Indian Journal of Clinical Biochemistry, 2003, 18 (2) 150-153
http://hdl.handle.net/123456789/78
 
Description Despite enormous research in the field of hypertension, its pathophysiology still remains largely unresolved and appears to be multifactorial. In the present communication, we have analyzed the status of nitric oxide (NO) in the patients with essential hypertension and age matched controls. We have found that the levels of NO are lowered in essential hypertension. The normalization of blood pressure by administration of antihypertensive therapy causes rise in the NO level indicating that perturbed NO status in essential hypertension is reversible. Addition of antioxidant to the antihypertensive drugs causes a further, though non significant, rise in the levels of NO, suggesting that antioxidants may be combined with antihypertensive drugs as adjunct in the management of essential hypertension.
 
Format 100604 bytes
application/pdf
 
Language en
 
Subject Nitric oxide
Essential hypertension
Antihypertensive treatment
Antioxidants
 
Title REVERSIBLE SUPPRESSION OF NITRIC OXIDE SYSTEM IN ESSENTIAL HYPERTENSION
 
Type Article